New Delhi, Dec 23 (IANS) A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection.All three doses and regimens of the vaccine named HeV-sG-V demonstrated to be safe and generated an immune response, according to the researchers in the study published in the journal The Lancet.”The induction of antibodies within 1 month of vaccination, along with the persistence afforded by two dosages, suggests the vaccine ca…
Trending
- Tumbadchi Manjula (2026) Movie Review: A Delightful Marathi Comedy That Wins Hearts With Its Village Charm
- Mollywood Times (2026) Review: Naslen Shines in a Bold, Bittersweet Love-Hate Letter to Malayalam Cinema
- Sannidhanam P.O. Movie Review: A Devotional Drama That Speaks From the Heart
- The Pyramid Scheme Exposes the Fast-Money Dreams Destroying Middle-Class India
- Brown (2026) Review: Karisma Kapoor Delivers a Career-Defining Performance in This Hauntingly Beautiful Zee5 Crime Drama
- Gullak Season 5 Review: The Mishras Are Back and More Heartwarming Than Ever
- Mango Pachcha Review (2026): A Gritty Crime Drama That Hits Close to Home
- Peddi (2026) Movie Review: Ram Charan’s Career-Best Performance Powers a Stirring Tale of Grit, Identity and Belonging
